The DOI matches its Crossref record; 150 of the 151 references it cites were found in a registry or an index.
The Interleukin-1 Family: Back to the Future
Open accessAbstract
Interleukin-1 (IL-1) is a central mediator of innate immunity and inflammation. The IL-1 family includes seven ligands with agonist activity (IL-1α and IL-1β, IL-18, IL-33, IL-36α, IL-36β, IL-36γ), three receptor antagonists (IL-1Ra, IL-36Ra, IL-38), and an anti-inflammatory cytokine (IL-37). Members of the IL-1 Receptor (IL-1R) family include six receptor chains forming four signaling receptor complexes, two decoy receptors (IL-1R2, IL-18BP), and two negative regulators (TIR8 or SIGIRR, IL-1RAcPb). A tight regulation via receptor antagonists, decoy receptors, and signaling inhibitors ensures a balance between amplification of innate immunity and uncontrolled inflammation. All cells of the innate immune system express and/or are affected by IL-1 family members. Moreover, IL-1 family members play a key role in the differentiation and function of polarized innate and adaptive lymphoid cells. Here we will review the key properties of IL-1 family members, with emphasis on pathways of negative regulation and orchestration of innate and adaptive immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, NLRP3 inflammasome activation reduces phagocytosis of Aβ by microglial cells, thus increasing the Aβ depositions and contributing to the pathogenesis of AD (Garlanda et al., 2013; Gold and El Khoury, 2015).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Garlanda et al., 2013
In the citing paper
“Interleukin-18 is a member of the large interleukin-1 family40 that has recently been associated with cytokine storm disorders.”
From Cytokine storm (2020) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Self-citationSuccinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176 · cited 1×
“Accumulation of succinate in classically Immunity 39, December 12, 2013 ª2013 Elsevier Inc. 1005 activatedM1macrophages (Tannahill et al., 2013) stabilizes hypoxia-inducible factor a (HIF-1a), which in turn induces IL-1b.”
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 1×
“Accordingly, IL-1 is required for development of Th17 cell-sustained autoimmunity (e.g., Chung et al., 2009; Sutton et al., 2006; Veldhoen et al., 2006).”
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 9×
“IL-1 affects virtually all cells and organs and is a major pathogenic mediator of autoinflammatory, autoimmune, infectious, and degenerative diseases (Dinarello, 2009, 2010; Dinarello et al., 2012; Gabay et al., 2010; Sims and Smith, 2010) (Table 2).”
InfluentialSelf-citationNeutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3024 · Cited by 3,159 · cited 1×
“IL-1 markedly prolongs the lifespan and stimulates the effector function of neutrophils and macrophages (Mantovani et al., 2011).”
Non-canonical inflammasome activation targets caspase-11
Kayagaki, N., Warming, S., Lamkanfi, M., Walle, L. V., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S., et al. (2011) · Nature · doi:10.1038/nature10558 · Cited by 2,530
Innate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Disanto, J. D., Eberl, G., Koyasu, S., Locksley, R., McKenzie, A., Mebius, R., et al. (2013) · Nature reviews. Immunology · doi:10.1038/nri3365 · Cited by 2,380 · cited 4×
“The discovery of innate lymphoid cells and the dissection of pathways of T cell differentiation have revealed essential functions for IL-1, IL-18, and IL-33 and have opened vistas on their functions (O’Shea and Paul, 2010; Spits et al., 2013).”
InfluentialInterleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248 · cited 4×
“Extracellular cleavage of the inactive IL-1b precursor by neutrophil enzymes such a proteinase-3 and elastase generate active IL-1b because the cleavage site is close to that of caspase-1 (Dinarello, 2011).”
InfluentialNuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M. G., Langford, T. K. A., Bucks, C. M., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 2,079 · cited 2×
“IL-33 plays a protective role against parasites ranging from nematode expulsion to control of Toxoplasma gondii encephalitis (Moro et al., 2010; Neill et al., 2010).”
A Large-Scale, Consortium-Based Genomewide Association Study of Asthma
Moffatt, M. F., Gut, I. G., Démenais, F., Strachan, D. P., Bouzigon, E., Heath, S. C., von Mutius, E., Farrall, M., Lathrop, M. G., & Cookson, W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906312 · Cited by 2,043 · cited 1×
“In humans, genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) in the genes encoding ST2 and IL-33 associated with asthma (Moffatt et al., 2010).”
Flagged first, then by citations
1 of the 151 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Yousif, 2011, Expression of IL-37 in mouse protects the myocardium against ischemic injury via modulation of NF-κB activation, Circulation, 124, A8603
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Interleukin-1 Blockade: An Update on Emerging Indications
Mistry, A., Savic, S., & van der Hilst, J. C. H. (2017) · BioDrugs · doi:10.1007/s40259-017-0224-7 · Cited by 21
New perspectives on the regulation of type II inflammation in asthma
Becerra-Díaz, M. (2017) · F1000Research · doi:10.12688/f1000research.11198.1 · Cited by 21
Cathepsin B‐mediated CD18 shedding regulates leukocyte recruitment from angiogenic vessels
Nakao, S., Zandi, S., Sun, D., & Hafezi‐Moghadam, A. (2017) · The FASEB Journal · doi:10.1096/fj.201601229r · Cited by 21
“IL-1b is critically involved in the acute inflammatory response, activation, and chemotaxis of inflammatory and antigen presenting cells, up-regulation of adhesion molecules, and neovascularization (14).”
BackgroundHussain, N., Zhu, W., Jiang, C., Xu, J., Geng, M., Wu, X., Hussain, S., Wang, B., Rajoka, M. S. R., Li, Y., et al. (2018) · Bioscience Reports · doi:10.1042/bsr20180003 · Cited by 21
Interleukin-37: The Effect of Anti-Inflammatory Response in Human Coronary Artery Endothelial Cells
Yan, X., Xie, B., Wu, G., Hu, J., Wang, D., Cai, X., & Li, J. (2019) · Mediators of Inflammation · doi:10.1155/2019/2650590 · Cited by 21
“Silencing of IL-37 in human blood monocytes results in a 2- to 3-fold increase in LPS and IL-1b-induced cytokines, suggesting that endogenous IL-37 serves as a natural brake of inflammation [6].”
BackgroundST2/MyD88 deficiency protects mice against aGVHD and spares T-regulatory cells
Griesenauer, B., Jiang, H., Yang, J.-F., Zhang, J.-L., Ramadan, A., Egbosiuba, J. C., Campa, K. A., & Paczesny, S. (2019) · Journal of Immunology · doi:10.4049/jimmunol.1800447 · Cited by 18
“The upstream receptors for MyD88 include the IL-1R superfamily and the TLR family, with the exception of TLR3 (25, 26).”
BackgroundScophthalmus maximus interleukin-1β limits Edwardsiella piscicida colonization in vivo
Chen, S., Ma, X., Wu, D., Yang, D., Zhang, Y., & Liu, Q. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.10.050 · Cited by 21
Lauritano, D., Ronconi, G., Caraffa, A., Gallenga, C. E., Kritas, S. K., Emidio, P. D., Martinotti, S., Tetè, G., Ross, R., & Conti, P. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109687 · Cited by 21
IL-1α and colorectal cancer pathogenesis: Enthralling candidate for anti-cancer therapy
Cheng, K. J., Mohamed, E. H. M., Khong, T. L., Zain, S. M., Thavagnanam, S., & Ibrahim, Z. A. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103398 · Cited by 21
Protective and Healing Effects of Ghrelin and Risk of Cancer in the Digestive System
Ginter, G., Ceranowicz, P., & Warzecha, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910571 · Cited by 21
Mitra, S., Schiller, D., Anderson, C., Gamboni, F., D’Alessandro, A., Kelher, M., Silliman, C. C., Banerjee, A. M., & Jones, K. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189536 · Cited by 21
Milanović, M., Bekić, M., Đokić, J., Vučević, D., Čolić, M. J., & Tomić, S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91109 · Cited by 22
“Accord-ingly, Wu et al. (30) showed that the dietary uptake of non-esterified αKG down -regulated intestinal expression of proinflammatory markers TLR4, NF-kB and mRNA for TNF-α in Cyprinus carpio infected with Aeromonas hydrophila .”
Programmable protein ligation on cell surfaces
Kofoed, C., Erkalo, G., Tay, N. E. S., Ye, X., Lin, Y., & Muir, T. W. (2025) · Nature · doi:10.1038/s41586-025-09287-2 · Cited by 27
“Interleukin-1β (IL-1β) is a key pro-inflammatory cytokine with a broad range of immune activities, including the stimulation of antigen-presenting cells, natural killer cells and CD4 + /CD8 + T cells 35 (Extended Data Fig.”
Xu, F., Ji, Q., Zhang, J., Huang, W., Cao, Z., & Li, Y. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.06.171 · Cited by 20
Nguyen, J., Gibbons, C. M., Dykstra-Aiello, C., Ellingsen, R., Koh, K. M. S., Taishi, P., & Krueger, J. M. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00366.2019 · Cited by 20
Wu, L., Zhou, C., Wu, J., Chen, S., Tian, Z., & Du, Q. (2020) · Mediators of Inflammation · doi:10.1155/2020/6959741 · Cited by 21
“NLRP3 inflammasome activation results in the secretion of proinflammatory cytokines, including IL-1β and IL-18, contributing to the systemic inflammatory response [19, 20].”
BackgroundKang, A.-R., Cho, J., Lee, N.-G., Kwon, J., Song, J., Hwang, S., Jung, I. S., Kim, J., Um, H., Oh, S. C., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.057 · Cited by 20
Induction of the IL-1RII decoy receptor by NFAT/FOXP3 blocks IL-1β-dependent response of Th17 cells
Kim, D. H., Kim, H. Y., Cho, S., Yoo, S.-J., Kim, W., Yeon, H. R., Choi, K., Choi, J., Kang, S. W., & Lee, W. (2021) · eLife · doi:10.7554/elife.61841 · Cited by 21
Soni, H., Kumar, R., Kanthakumar, P., & Adebiyi, A. (2021) · The FASEB Journal · doi:10.1096/fj.202100367r · Cited by 20
“We present data in this study demonstrating that (1) the beta isoform of IL1 is a potent inducer of Ca2+ entry in murine GMCs, (2) TRPA1 channels are expressed in mouse GMCs and mediate intracellular storeindependent Ca2+ entry, and (3) IL1β increases [Ca]i via TRPA1 channels.”
Anakinra treatment for refractory cerebral autoinflammatory responses
Jang, Y., Lee, W., Lee, H. S., Chu, K., Lee, S. K., & Lee, S. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51500 · Cited by 19
“Anakinra controls dysregulated innate immunity by blocking IL-1-mediated autoinflammatory reactions.11 Systemically, myeloid cells play a crucial role in generating autoinflammasomes by recognizing pathogenassociated molecular patterns or damage-associated molecular patterns and potentiating the autoinflammatory respo…”
BackgroundYip, F., Lai, B., & Yang, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097717 · Cited by 22
Ciucis, C. G. D., Fruscione, F., Paolis, L. D., Mecocci, S., Zinellu, S., Guardone, L., Franzoni, G., Cappelli, K., & Razzuoli, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311096 · Cited by 20
“IL-1Ra binds the receptor IL-1R1 with a higher affinity than IL-1α or IL-1β, although without activation of the IL-1 signaling [61].”
BackgroundInfluentialTransgenic mouse model for imaging of interleukin-1β-related inflammation in vivo
Iwawaki, T., Akai, R., Oikawa, D., Toyoshima, T., Yoshino, M., Suzuki, M., Takeda, N., Ishikawa, T., Kataoka, Y., & Yamamura, K. (2015) · Scientific Reports · doi:10.1038/srep17205 · Cited by 20
Present and future of biologic drugs in primary Sjögren’s syndrome
Sambataro, D., Sambataro, G., Bosco, Y. D., & Polosa, R. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1235698 · Cited by 20
“IL-1 is one of the most important cytokine of the classic Th1 pathway and plays a critical role in innate immunity, stimulating the recruitment and the local amplification of innate and adaptative immunity, acting on the endothelial cells to produce adhesion molecules and on the hypothalamus to increase body temperatu…”
BackgroundLin, W.-H. W., Nelson, A. N., Ryon, J. J., Moss, W. J., & Griffin, D. E. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix012 · Cited by 20
Kulkarni, N. N., Adase, C. A., Zhang, L., Borkowski, A. W., Li, F., Sanford, J. A., Coleman, D. J., Aguilera, C., Indra, A. K., & Gallo, R. L. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.07.814 · Cited by 20
“These mechanisms include proteolytic activation of ligands by the inflammasome, receptor antagonists, decoy receptors, and negative regulators (Garlanda et al., 2013b; Palomo et al., 2015).”
Eckhart, L., & Tschachler, E. (2018) · Experimental Dermatology · doi:10.1111/exd.13700 · Cited by 21
Ding, L., Zhao, X., Zhu, N., Zhao, M., Hu, Q., & Ni, Y. (2019) · Surgical Oncology · doi:10.1016/j.suronc.2019.12.001 · Cited by 20
IL-36 Signaling in the Tumor Microenvironment
Chelvanambi, M., Weinstein, A. M., & Storkus, W. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38315-2_8 · Cited by 23
Mezzasoma, L., Bellezza, I., Orvietani, P., Manni, G., Gargaro, M., Sagini, K., Llorente, A., Scarpelli, P., Pascucci, L., Cellini, B., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101657r · Cited by 20
Fu, H., Spieler, F., Großmann, J., Riemann, D., Larisch, M., Hiebl, B., Schlecht, K., Jaschke, C., Bartling, B., Hofmann, B., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.002 · Cited by 20
Ghonime, M. G., Mitra, S., El-Domany, R. A., Wewers, M. D., & Gavrilin, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127278 · Cited by 18
The epithelium-derived inflammatory mediators of chronic rhinosinusitis with nasal polyps
Wang, C.-S., Yan, B., & Zhang, L. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1723417 · Cited by 16
“Similarly, IL-36, another member of IL-1 superfamily, is released by several cell types; including epithelial cells, immune cells, neuron cells, and keratinocytes [118].”
BackgroundShah, M.-A., Park, D.-J., Kang, J.-B., Kim, M. O., & Koh, P. (2020) · Laboratory Animal Research · doi:10.1186/s42826-020-00058-w · Cited by 19
Pianko, M. J., & Golob, J. L. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10033-7 · Cited by 20
“IL-1 family cytokines are critical mediators of this type of inflammation [87].”
BackgroundIL‐38 attenuates myocardial ischemia–reperfusion injury by inhibiting macrophage inflammation
Wei, Y., Xing, J., Su, X., Li, X., Yan, X., Zhao, J., & Tao, H. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.898 · Cited by 19
“IL‐38 has been identified as having similar biological activities to IL‐1 family members because of its homology with other IL‐1F members.(37) It has been reported that IL‐38 mainly functions as a typical receptor antagonist in inflammation regulation similar to IL‐1Ra and IL‐36Ra, and inhibits the IL‐36 signaling pat…”
BackgroundRuan, Z., Fu, X., Li, W., Ye, J., Wang, R.-Z., & Zhu, L. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.078 · Cited by 19
Differential Kinetics of Aspergillus nidulans and Aspergillus fumigatus Phagocytosis
Gresnigt, M. S., Becker, K. L., Leenders, F., Alonso, M. F., Wang, X., Meis, J. F. G. M., Bain, J. M., Erwig, L. P., & van de Veerdonk, F. L. (2017) · Journal of Innate Immunity · doi:10.1159/000484562 · Cited by 18
Selenium in Graves Hyperthyroidism and Orbitopathy
Marinò, M., Menconi, F., Dottore, G. R., Leo, M., & Marcocci, C. (2018) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000001136 · Cited by 19
“In this regard, a highly speculative hypothesis involves the IL1-receptor antagonist, a natural competitor for binding to the IL1-receptor that is synthesized and released by the same cells that produce IL1.”
BackgroundMechanistic Pathways of Selenium in the Treatment of Graves’ Disease and Graves’ Orbitopathy
Marinò, M., Dottore, G. R., Leo, M., & Marcocci, C. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0658-7889 · Cited by 19
“Not only immunocompetent cells, but also fibroblasts are capable of releasing pro-inflammatory cytokines in response to oxidative stress, in particular TNFα, IL1β, and IFNγ [42].”
BackgroundInfluentialLv, K., Wang, G., Shen, C., Zhang, X., & Yao, H. (2018) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2018.10.003 · Cited by 19
Griffin, M., Kalaskar, D. M., & Butler, P. E. M. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0477-z · Cited by 19
An Insight into COPD Morphopathogenesis: Chronic Inflammation, Remodeling, and Antimicrobial Defense
Vitenberga-Verza, Z., Pilmane, M., & Babjoniševa, A. (2019) · Medicina · doi:10.3390/medicina55080496 · Cited by 20
“Moreover, release of IL-1α from immune and non-immune cells can initiate a whole cascade of other cytokine release [52].”
BackgroundPathogenic functions and diagnostic utility of cytokines/chemokines in EHEC‐HUS
Shimizu, M. (2019) · Pediatrics International · doi:10.1111/ped.14053 · Cited by 19
ANO9 Regulated Cell Cycle in Human Esophageal Squamous Cell Carcinoma
Katsurahara, K., Shiozaki, A., Kosuga, T., Kudou, M., Shoda, K., Arita, T., Konishi, H., Komatsu, S., Kubota, T., Fujiwara, H., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08368-y · Cited by 19
Cao, Z., Li, Y., Wang, W., Jie, S., Hu, X., Zhou, J. H., Wu, T., Aili, D., Long, Z., Li, Y., et al. (2020) · BioMed Research International · doi:10.1155/2020/9013283 · Cited by 20
Jiang, L., Zhou, X., Huang, C., Bao, J., Li, J., Xu, K., Dong, D., & Wu, L. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107489 · Cited by 19
IL-33/ST2 involves the immunopathology of ocular toxoplasmosis in murine model
Tong, X., & Lü, F. (2015) · Parasitology Research · doi:10.1007/s00436-015-4377-3 · Cited by 19
“ST2 is expressed on various innate and adaptive immune cell types including macrophages and the newly identified Th2 innate lymphoid cells and drives the production of Th2 cytokines, which are responsible of protective Th2 inflammatory responses in infection and tissue repair (Garlanda et al. 2013).”
BackgroundÇomaklı, S., Sevim, Ç., Kontadakis, G. A., Doğan, E., Taghizadehghalehjoughi, A., Özkaraca, M., Aschner, M., Νikolouzakis, Τ. Κ., & Tsatsakis, A. M. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.01.004 · Cited by 19
All about the caspase-dependent functions without cell death
Baena-López, L. A. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.01.005 · Cited by 19
Tan, C., Ma, H., Chen, J., Ma, G., Jha, A., Tan, S., Zhu, Y., Liu, M., Liu, K., Xiao, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202502297 · Cited by 18
Homozygous IL1RN Mutation in Siblings with Deficiency of Interleukin-1 Receptor Antagonist (DIRA)
Ziaee, V., Youssefian, L., Faghankhani, M., Jazayeri, A. R., Saeidian, A. H., Vahidnezhad, H., & Uitto, J. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00767-w · Cited by 18
“Deficiency in the IL-1-receptor antagonist (IL-1RA), which is associated with DIRA, leads to endogenously produced IL-1β to bind to the corresponding receptor continuously, resulting in enhanced signaling pathway to increase proinflammatory mediators [20].”
BackgroundSaeki, A., Tsuchiya, K., Suda, T., Into, T., Hasebe, A., Suzuki, T., & Shibata, K. (2020) · Immunology · doi:10.1111/imm.13230 · Cited by 17
Banu, S., Gaur, N., Nair, S., Ravikrishnan, T., Khan, S. A., Mani, S., Bharathi, S., Mandal, K., Kuram, N. A., Vuppaladadium, S., et al. (2022) · Genomics · doi:10.1016/j.ygeno.2022.110300 · Cited by 18
Liu, Q., Zhang, Y., Zhu, C., Liu, W., Ma, X., Chen, J., Mo, S., Dong, L., Wang, N., Wu, J., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.818789 · Cited by 18
Pentachlorophenol mediated regulation of DAMPs and inflammation: In vitro study
Thota, S., Begum, R., Kaur, G., Bagam, P., Dorsey, W. C., & Batra, S. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105378 · Cited by 18
Soluble ST2 is increased in systemic lupus erythematous and is a potential marker of lupus nephritis
Moreau, A., Nicaise, C., Awada, A., & Soyfoo, M. S. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/eg3a2k · Cited by 18
“and to its coreceptor IL-1R accessory protein (IL-1RacP) ensuing activation of NFκB and MAPK 6 pathways and leading to cell-specific downstream effects (12, 14, 15, 17, 18).”
BackgroundKozyra, P., & Pitucha, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168874 · Cited by 21
The innate and T-cell mediated immune response during acute and chronic gammaherpesvirus infection
Rex, V., Zargari, R., Stempel, M., Halle, S., & Brinkmann, M. M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1146381 · Cited by 19
“The antiviral innate immune response also initiates and shapes the adaptive immune response with its central players, the cytotoxic CD8+ T cells (CTL), CD4+ T helper cells, and B cells (Tomalka et al., 2022).”
BackgroundInfluentialImmune modulation through secretory autophagy
Weigert, A., & Herhaus, L. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30427 · Cited by 18
“83,84 This question is furthermore relevant when looking at other inflammation ‐ related cargo being released via secretory autophagy.”
Narros‐Fernández, P., Basavarajappa, S. C., & Walsh, P. T. (2023) · FEBS Journal · doi:10.1111/febs.16888 · Cited by 19
“The two isoforms of IL-1, IL-1 a and IL-1 b , bind to the same transmembrane receptor complex, formed by IL-1R1 and the IL-1R accessory protein (IL-1RAcp) and have similar biological properties, however, they also share some dissimilarities [74 – 76].”
BackgroundFranzoni, G., Mecocci, S., Ciucis, C. G. D., Mura, L., Dell’Anno, F., Zinellu, S., Fruscione, F., Paolis, L. D., Carta, T., Anfossi, A. G., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1209898 · Cited by 18
“IL-1 a and IL-1 b are interleukins produced and released at the early stages of infections, characterized by similar biological properties (56).”
InfluentialZou, Y.-T., Li, J., Chai, J.-Y., Hu, Y., Zhang, W., & Zhang, Q. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149513 · Cited by 20
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate
Le, T. T., Skak, K., Schroder, K., Schroder, W. A., Boyle, G. M., Pierce, C. J., & Suhrbier, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153975 · Cited by 18
“The data so far supports the view that IL-1 promotes the anti-cancer efficacy of ingenol mebu-tate by promoting neutrophil anti-cancer activity, with MyD88 required for IL-1 receptor signal transduction [42].”
Chen, K., Shanmugam, N. K. N., Pazos, M. A., Hurley, B. P., & Cherayil, B. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160937 · Cited by 19
“IL-1ß plays important roles in several aspects of innate and adaptive immune responses and can contribute to the pathology of chronic inflammatory diseases when its production is dysregulated [3,4].”
Ibrahim, A. A., Salem, R. M., El-Shimi, O. S., Baghdady, S. M., & Hussein, S. (2018) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.12516 · Cited by 18
“IL-1A is a member of the IL-1 cytokine family which plays a major role in inflammation and fibrosis in multiple tissues.(4) In vitro and in vivo studies demonstrated that keratinocytes secrete IL-1A when stimulated by P.”
BackgroundRouse, B. T., & Mueller, S. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00025-9 · Cited by 18
Guo, Y., Li, H., Ding, C., Han, S., & Wang, J. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24324 · Cited by 18
Dong, H., Zheng, L., Duan, X., Zhao, W., Chen, J., Liu, S., & Sui, G. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.04.203 · Cited by 18
Khan, W. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.68834 · Cited by 19
Scaffolds for corneal tissue engineering
Yousaf, S., Keshel, S. H., Farzi, G. A., Momeni-Moghadam, M., Ahmadi, E. D., Asencio, Í. O., Mozafari, M., & Sefat, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102561-1.00026-9 · Cited by 18
MAP3K2 augments Th1 cell differentiation via IL-18 to promote T cell-mediated colitis
Wu, N., Chen, D., Sun, H., Tan, J., Zhang, Y., Zhang, T., Han, Y., Liu, H., Ouyang, X., Yang, X., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1720-9 · Cited by 18
IL-1β primed mesenchymal stromal cells moderate hemorrhagic shock-induced organ injuries
Aussel, C., Baudry, N., Grosbot, M., Caron, C., Vicaut, É., Banzet, S., & Peltzer, J. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02505-4 · Cited by 18
Bone marrow fat and the decline of B lymphopoiesis in rabbits
Kennedy, D. E., Witte, P. L., & Knight, K. L. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.11.003 · Cited by 18
“IL-1β is expressed as a full length, inactive precursor, and inflammasome activation is required for cleavage of pro-IL1β into its active form by caspase-1 (Garlanda et al., 2013).”
Backgroundde Souza, C. A., de Souza, A. Q. A., de Souza, M. D. S. Q. A., Leite, J. A. D., de Morais, M. S., & Rabenhorst, S. H. B. (2017) · Acta Orthopaedica · doi:10.1080/17453674.2017.1348439 · Cited by 18
Hirata, T., Koga, K., Johnson, T. A., Morino, R., Nakazono, K., Kamitsuji, S., Akita, M., Kawajiri, M., Kami, A., Hoshi, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25065-9 · Cited by 18
The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
Allegra, A., Innao, V., Tartarisco, G., Pioggia, G., Casciaro, M., Musolino, C., & Gangemi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205226 · Cited by 18
“IL-33 is regarded as an “alarmin” able to stimulate several effectors of the immune system, regulating numerous immune responses comprising cancer immune reactions [6,7] (Figure 1).”
BackgroundBouillot, S., Pont, S., Gallet, B., Moriscot, C., Deruelle, V., Attrée, I., & Huber, P. (2020) · Cellular Microbiology · doi:10.1111/cmi.13251 · Cited by 18
“However, extremely low amounts of IL-1β is nevertheless sufficient to induce inflammatory reactions, as previously noted (Garlanda et al., 2013).”
BackgroundInfluentialCytokines and Chemokines in Tumor Growth and Progression
Mir, M. A., Rashid, M., & Jan, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-4657-0_2 · Cited by 17
An Interleukin-1 Beta-Encoding Retrovirus Exhibits Enhanced Replication In Vivo
Browne, E. P. (2014) · Journal of Virology · doi:10.1128/jvi.02314-14 · Cited by 16
“Since IL-1R1 is broadly expressed in the immune system, IL-1 can affect many different immune lineages (16).”
BackgroundMcSharry, C. P., Spears, M., Chaudhuri, R., Cameron, E. J., Husi, H., & Thomson, N. C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.022 · Cited by 17
Evaluation of immunogenicity and protection mediated by Lawsonia intracellularis subunit vaccines
Fourie, K. R., Choudhary, P., Ng, S. H., Obradovic, M. R., Brownlie, R. M., Anand, S. K., & Wilson, H. L. (2021) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2021.110256 · Cited by 17
Ducza, L., Szűcs, P., Hegedűs, K., Bakk, E., Gajtkó, A., Wéber, I., & Holló, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111408 · Cited by 17
Ling, Y., Xiao, M., Huang, Z., Xu, H. Z., Huang, F., Ren, N., Chen, C., Lu, D. M., Yao, X., Xiao, L.-N., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/4836992 · Cited by 18
“However, they can be transported outside with the assistance of the GSDMD protein related to perforation [28].”
BackgroundYu, E., Zhang, E., Lv, X., Lin, Y., Lin, Z., Siaw-Debrah, F., Zhang, Y., Yang, S., Ruan, L., Zhuge, Q., et al. (2022) · Journal of Neurotrauma · doi:10.1089/neu.2021.0318 · Cited by 17
“53 Most cytokines contain a signal sequence that guides their cellular exit via secretory vesicles; however, the IL-1 family (including IL-1 b and IL-18) lacks a signal peptide to guide secretion via the endoplasmic reticulum to the Golgi secretory pathway.”
Dang, K., Zhang, N., Gao, H., Wang, G., Liang, H., & Xue, M. (2023) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14888 · Cited by 18
Muhammad, W., Zhang, Y., Zhu, J., Xie, J., Wang, S., Wang, R., Feng, B., Zhou, J., Chen, W., Xu, Y., et al. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213621 · Cited by 17
Yip, K. H.-K., Braverman, G., Yue, L., & Fields, T. R. (2023) · Current Rheumatology Reports · doi:10.1007/s11926-023-01128-3 · Cited by 17
“…IL-1β is a potent mediator of the innate immune response with pleiotropic effects throughout the body, including induction of fever, stimulation of the hypothalamic-pituitary-adrenal axis, endothelial activation, promotion of neutrophil trafficking, and differentiation of lymphoid cells [40].”
Interleukin-1 regulates follicular T cells during the germinal center reaction
Belbézier, A., Engeroff, P., Fourcade, G., Vantomme, H., Vaineau, R., Gouritin, B., Bellier, B., Brochériou, I., Tchitchek, N., Graff‐Dubois, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1393096 · Cited by 15
“Interleukin-1 a and b (IL-1) are mainly known as potent proin fl ammatory cytokines in innate immunity (1 – 3).”
BackgroundInfluentialZhang, C., Zhou, J., Zhuo, L., Zhang, W., Lv, L., Zhu, L., Zhang, J., Feng, F., Liu, W., Han, L., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118391 · Cited by 18
Barbhuiya, P. A., Ahmed, A., Dutta, P. P., Sen, S., & Pathak, M. P. (2025) · Current Nutrition Reports · doi:10.1007/s13668-024-00598-w · Cited by 18
“Furthermore, IL-1β promotes local inflammation by triggering the production of IL-6, which is another cytokine that promotes inflammation [101].”
Liu, Z., Zhang, M., Wu, J. S., Zhou, P., Liu, Y., Wu, Y., Yang, Y., & Lü, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131086 · Cited by 17
“The binding receptors for IL-1β include CD121a, which is responsible for triggering IL-1-mediated inflammation, and the type II IL-1 receptor, which acts as non-signaling decoy receptor [7].”
BackgroundTakahashi, K., & Ohta, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.082 · Cited by 17
“The released IL-1a precursor is fully active and functions as a tissue injury alarm molecule, an alarmin [14].”
BackgroundIntrathecal cytokine profile in neuropathy with anti‐neurofascin 155 antibody
Ogata, H., Zhang, X., Yamasaki, R., Fujii, T., Machida, A., Morimoto, N., Kaida, K., Masuda, T., Ando, Y., Kuwahara, M., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50931 · Cited by 17
Cao, S., Zhu, L., Zhu, C., Feng, J., Yin, J., Jin, L., Xu, Y., Yang, H., Huang, Y., & Zhang, Q. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.139 · Cited by 18
Tyrkalska, S. D., Candel, S., & Mulero, V. (2020) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2020.103874 · Cited by 18
Dragoljevic, D., Lee, M. K. S., Louis, C., Shihata, W., Kraakman, M. J., Hansen, J. A., Masters, S. L., Hanaoka, B. Y., Nagareddy, P. R., Lancaster, G. I., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1206 · Cited by 17
“In vivo, the biological function of IL-1b is tightly regulated by two natural inhibitors: the decoy receptor IL-1 type 2 receptor (IL-1R2) and the IL-1R antagonist (IL-1Ra) which binds to the membrane-bound IL-1 type 1 receptor (IL-1R1).(6) Human IL-1Ra also binds to murine IL-1R to prevent signalling.”
BackgroundFeng, L., Tian, R.-F., Mu, X., Chen, C., Zhang, Y., Cui, J., Song, Y., Liu, Y., Zhang, M., Shi, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.817377 · Cited by 20
“Interleukin 1 beta (IL1b) is a central mediator of innate immunity and inflammation (59) that was first identified as being responsible for resistance against microbes (60).”
BackgroundC/EBPβ is a transcriptional key regulator of IL-36α in murine macrophages
Nerlich, A. G., Ruangkiattikul, N., Laarmann, K., Janze, N., Dittrich‐Breiholz, O., Kracht, M., & Goethe, R. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.06.002 · Cited by 17
IL-22 Signaling in the Tumor Microenvironment
Jiang, R., & Sun, B. (2021) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-55617-4_5 · Cited by 35
Metadata
- Authors
- Garlanda, C., Dinarello, C. A., & Mantovani, A.
- Affiliations
- Radboud University Medical Center (NL)
- University of Milan (IT)
- Corresponding author
- Mantovani, Alberto
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 39
- Issue
- 6
- Pages
- 1003-1018
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC3933951
- OpenAlex
- W2145866317
- Cited by
- 1,945
- References
- 151
- Citations by year
- 2026: 80 · 2025: 118 · 2024: 136 · 2023: 122 · 2022: 168 · 2021: 172 · 2020: 202 · 2019: 165 · 2018: 194 · 2017: 192 · 2016: 171 · 2015: 156 · 2014: 66 · 2013: 1
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- European Research Council
- Associazione Italiana per la Ricerca sul Cancro
- National Institutes of Health (A115614, AR-45584)
- European Commission (FP7-HEALTH-2011- ADITEC 280873)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- interleukin-1 family, innate immunity, inflammation, IL-1 receptor family, interleukin-1 receptor antagonist, decoy receptor, IL-18, IL-33, IL-36, IL-37, IL-38, IL1RAP, SIGIRR, negative regulation of cytokine signaling, lymphocyte differentiation, innate and adaptive immunity
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Immunity, Innate, Interleukin-1, Interleukins, Ligands, Receptors, Interleukin-1, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review